SLMO1 Inhibitors
SLMO1 inhibitors are hypothetical chemical compounds that specifically target and inhibit the activity of SLMO1 (Slowmo Homolog 1), a mitochondrial transmembrane protein. SLMO1 is believed to play a role in mitochondrial dynamics, particularly in processes such as mitochondrial fusion and fission, which are essential for maintaining mitochondrial integrity and function. These dynamics are crucial for energy production, regulation of apoptosis, and overall cellular homeostasis. By influencing mitochondrial morphology and distribution, SLMO1 contributes to the proper functioning of cellular metabolism and the cellular response to stress.
While specific SLMO1 inhibitors have not been extensively characterized or reported in scientific literature, the theoretical development of such inhibitors would involve compounds that could bind to functional domains of the SLMO1 protein, disrupting its normal activity. Inhibiting SLMO1 could lead to alterations in mitochondrial dynamics, potentially affecting ATP production, reactive oxygen species generation, and programmed cell death pathways. Research into SLMO1 and the potential effects of its inhibition is important for understanding the complex mechanisms of mitochondrial regulation and how disruptions in these processes can impact cellular physiology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound can inhibit DNA methyltransferases, potentially leading to reduced methylation of the PRELID3A gene, which might suppress its expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, it can alter chromatin structure and potentially decrease PRELID3A gene transcription. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR signaling which could downregulate proteins involved in mitochondrial function, possibly including PRELID3A. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
This glucose analog may disrupt glycolysis and indirectly affect the energy status of cells, which could influence PRELID3A expression. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
As a PPAR-gamma agonist, it can modulate the transcription of various genes, which might include PRELID3A. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
By activating PPAR-alpha, fenofibrate can alter lipid metabolism and potentially reduce PRELID3A expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
It can modulate gene expression via the retinoic acid receptor, potentially affecting the transcription of PRELID3A. | ||||||
WY 14643 | 50892-23-4 | sc-203314 | 50 mg | $136.00 | 7 | |
This PPAR-alpha agonist might change the transcriptional landscape of lipid metabolism genes, possibly reducing PRELID3A expression. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
By inhibiting HMG-CoA reductase, it could alter lipid profiles and indirectly impact PRELID3A expression. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
It can act as an inhibitor of sirtuins, potentially affecting the expression of mitochondrial proteins such as PRELID3A. | ||||||